Indivior raises guidance for peak net revenue potential of Sublocade asset
Sharecast
Published Dec 07, 2022 08:59
Updated Dec 07, 2022 09:13
Indivior raises guidance for peak net revenue potential of Sublocade asset
Sharecast - Indivior stated net revenue run rates from its Sublocade injection will hit $1.0bn by the end of 2025, while on a long-term view, it now expects to deliver Sublocade peak potential net revenues of more than $1.5bn - based on the expected positive market dynamics for buprenorphine medication-assisted treatment and on continued execution against its OHS strategy.
The FTSE 250-listed firm also said it expects to achieve a double-digit percentage net revenue compound annual growth rate over the medium term, driven primarily by Sublocade in the United States and growing net revenue contributions from its risperidone for extended-release injection.
"Within this outlook, which is based on its current business portfolio, Indivior also expects a return to NR growth in the Rest of the World driven by new products Sublocade (Subutex PR) and Suboxone (buprenorphine/naloxone) Film. Additionally, the company assumes the U.S. market share of Suboxone Film, which it does not promote, will trend towards historical analogs for genericised medicines," said the group.
Indivior added that it expects to achieve "significant operating margin expansion" over the medium term, driven by an improving gross margin and focused management of operating expenses, and also said it had chosen the Nasdaq Composite for an additional share listing in the US.
As of 0855 GMT, Indivior shares were up 5.52% at 1,764.31p.
Reporting by Iain Gilbert at Sharecast.com
Read more on Sharecast.com
Get The App
Written By: Sharecast
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.